Effect of Different Supralottic Airway Devicess on Optic Nerve Sheath Diameter
The Effect of Supralottic Airway Devicess on Hemodynamic Response and Optic Nerve Sheath Diameter. PROSEAL LMA, SUPREMA LMA, I-JEL LMA
1 other identifier
observational
90
1 country
1
Brief Summary
Direct laryngoscopy and tracheal intubation are associated with increases in intraocular pressure (IOP), intracranial pressure (ICP), heart rate (HR), and blood pressure. The use of supraglottic airway devices (SADs) are known to be beneficial in overcoming the disadvantages of laryngoscopy and tracheal intubation, especially ocular and pressure stress responses. In recent years, it has been reported that ultrasonographic measurement of optic nerve sheath diameter (ONSD) can be used in the diagnosis of increased ICP. The aim of our study is to compare the effects of Proseal laryngeal mask airway (pLMA), Suprem laryngeal mask airway (sLMA) and I-gel on hemodynamic response and ONSD during insertion in adult patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
July 30, 2020
CompletedFirst Submitted
Initial submission to the registry
June 2, 2022
CompletedFirst Posted
Study publicly available on registry
August 12, 2022
CompletedAugust 12, 2022
August 1, 2022
1.1 years
June 2, 2022
August 11, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
OPTIC NERVE SHEATH DIAMETER
effects of different types of laryngeal masks onoptic nerve sheath diameter
10 min after using supraglottic airway devices
Study Arms (3)
pLMA(n=30)
sLMA(n=30)
I-jel(n=30)
Interventions
a SAD was inserted by all anaesthetists participating in the study had at least 3 years experience of airway management and were experienced with both the pLMA, sLMA and I-jel. Inadequate ventilation after two attempts was considered a failed placement, and these patients were excluded, while the practitioner was freed to use an alternative airway device.
Eligibility Criteria
90
You may qualify if:
- ASA physical status of I-II
- elective surgery
- non-ophthalmic procedures
- h duration
- general anaesthesia
- supine position
You may not qualify if:
- Mallampati and ASA status ≥III,
- a history or suspect of difficult airway,
- previous intracranial/ocular surgery,
- cerebral edema/high intracranial pressure,
- glaucoma,
- uncontrolled hypertension
- , diabetic retinopathy,
- obstetric patients,
- those who refused to participate in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Gamze Küçükosman
Zonguldak, 67600, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- medical doctor
Study Record Dates
First Submitted
June 2, 2022
First Posted
August 12, 2022
Study Start
July 1, 2019
Primary Completion
July 30, 2020
Study Completion
July 30, 2020
Last Updated
August 12, 2022
Record last verified: 2022-08
Data Sharing
- IPD Sharing
- Will not share